Zarrinkar, P. P., Gunawardane, R. N., Cramer, M. D., Gardner, M. F., Brigham, D., Belli, B., . . . Bhagwat, S. S. (2009). AC220 is a uniquely potent and selective inhibitor of FLT3 for the treatment of acute myeloid leukemia (AML). American Society of Hematology.
Stile di citazione ChicagoZarrinkar, Patrick P., et al. AC220 Is a Uniquely Potent and Selective Inhibitor of FLT3 for the Treatment of Acute Myeloid Leukemia (AML). American Society of Hematology, 2009.
Citazione MLAZarrinkar, Patrick P., et al. AC220 Is a Uniquely Potent and Selective Inhibitor of FLT3 for the Treatment of Acute Myeloid Leukemia (AML). American Society of Hematology, 2009.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.